Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
CAMP4 Therapeutics Corporation (CAMP) had Free Cash Flow per Share of $-9.81 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$0.65M |
|
$-51.79M |
|
-- |
|
$0.65M |
|
$53.74M |
|
$-53.09M |
|
$1.30M |
|
$-51.79M |
|
$-51.79M |
|
$-51.79M |
|
$-51.79M |
|
$-51.79M |
|
$-51.79M |
|
$-53.09M |
|
$-51.39M |
|
4.69M |
|
4.69M |
|
$-11.04 |
|
$-11.04 |
|
| Balance Sheet Financials | |
$66.38M |
|
$3.86M |
|
$11.92M |
|
$78.31M |
|
$9.60M |
|
$0.07M |
|
$5.57M |
|
$15.16M |
|
$63.14M |
|
$63.14M |
|
$63.14M |
|
20.14M |
|
| Cash Flow Statement Financials | |
$-45.56M |
|
$-0.44M |
|
$71.66M |
|
$40.00M |
|
$65.66M |
|
$25.66M |
|
$4.03M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.92 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
100.00% |
|
-8142.33% |
|
-8142.33% |
|
-7882.21% |
|
-7943.40% |
|
-7943.40% |
|
$-46.00M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-82.02% |
|
-82.02% |
|
-66.14% |
|
-81.93% |
|
$3.13 |
|
|
Free Cash Flow per Share |
$-9.81 |
$-9.71 |
|